Papers: 10.1186/s13058-019-1202-4

https://doi.org/10.1186/s13058-019-1202-4

Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer

Cited by: 16
Author(s): Jin Sung Lee, Susan E. Yost, Suzette Blanchard, Daniel Schmolze, Hongwei Yin, Raju Pillai, Kim Robinson, Aileen Tang, Norma Martínez, Jana Portnow, Wei Wen, John H. Yim, Heather Ann Brauer, Yuqi Ren, Thehang Luu, Joanne Mortimer, Yuan Yuan
Published: almost 7 years ago

Software Mentions 1